The Maxim Swift™ HIV Recent Infection Assay (RIA) is a single use qualitative immunoassay to detect the circulating antibodies to Human Immunodeficiency Virus Type 1 (HIV-1), Type 2 (HIV-2) and distinguish between recent and long-term infection in HIV-1/2. The assay is a point of care (POC) test intended for...

The Maxim Swift™ HIV Recent Infection Assay (RIA) Kit Controls are quality control reagents for use only with the Maxim Swift™ HIV Recent Infection Assay (RIA) (P/N 92002). They are used to verify that the test kit reagents are working and that the test is performed correctly. The Maxim Swift™ HIV RIA uses US CDC developed...

Maxim's FDA Approved HIV-1 Urine EIA test is an enzyme immunoassay for the in-vitro detection of antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) in urine. The test is intended for use in professional laboratory settings as an aid in clinical diagnosis of HIV infection. Before a determination of HIV-1 status can...

The Maxim HIV-1 Limiting Antigen-Avidity EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term. Persons with recently acquired HIV-1 infections typically exhibit HIV-1 specific IgG populations with higher...

The Maxim HIV-1 Limiting Antigen-Avidity EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term. Persons with recently acquired HIV-1....

Maxim's Cambridge Biotech HIV-1 Urine Western Blot Kit is an FDA approved in-vitro qualitative assay for the detection and identification of antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) contained in human urine. This more specific assay is used as a supplemental test with urine specimens that...